New York University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, New York University sits in the top decile of US sponsors by registered trial count (#271 of 15,742 sponsors by registered trial count).
New York University: 83 sponsored US clinical trials, 25 recruiting.
New York University sponsors 83 registered US clinical trials on ClinicalTrials.gov, 25 of them currently recruiting, and 51 completed. 2 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 5 trials.
Top-decile sponsor footprint
New York University ranks in the top decile of sponsors by registered trial count (#271 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
51 of 52 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
83 total, page 2 of 2
Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care
NCT03939455
Expressive Helping for Chinese-Speaking Cancer Patients and Survivors
NCT03945734
HIV Oral Testing Infographic Experiment
NCT04061915
Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy
NCT03737318
Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors
NCT03736213
Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain
NCT03855111
Efficacy of the Stroll Safe Outdoor Fall Prevention Program
NCT03624777
Mindful Parenting and Parent Training Program Study
NCT03796663
MBSR During AI Therapy for Breast Cancer
NCT03253627
staRt: Enhancing Speech Treatment With Smartphone-delivered Biofeedback
NCT04474691
Just Do You Program for Young Adults With Serious Mental IIlness
NCT03423212
Computer-based Intervention for Alcohol-using HIV/HCV+ Women
NCT03362476
Intervention for Persons Leaving Residential Substance Abuse Treatment
NCT02670902
Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations
NCT02801747
Stroll Safe Outdoor Fall Prevention Program
NCT02946593
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
NCT02829528
Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use
NCT03502525
Cornerstone Program for Transition-Age Youth Study Protocol for a Randomized Controlled Trial
NCT02696109
ACTIVATE: A Computerized Training Program for Children With ADHD
NCT02562469
Integrated Model for Promoting Parenting and Early School Readiness in Pediatrics
NCT02459327
Evaluating a Digital Health Information Tool
NCT02549599
Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage
NCT02421159
Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
NCT01571128
Person-Centered Care Planning and Service Engagement
NCT02299492
Improving Contraceptive Counseling in the United States
NCT02801266
Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline
NCT02086630
Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV
NCT01607541
A Parent-Based Intervention to Reduce Sexual Risk Behavior in Adolescents
NCT01326806
Couple & Family Contexts
NCT01631721
A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
NCT01013935
Dyadic, Skills-Based Primary Prevention for Partner Violence in Perinatal Parents
NCT02009111
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
NCT00067158
Interventions for HIV+ Mothers With Problem Drinking
NCT00183209
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 5 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the New York University pipeline
25 recruiting of 83 indexed (30% open); 51 completed (61%).
Phase mix: 2 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Depression (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
New York University: open-pipeline peers nationwide
Peers matched on 83 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
New York University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 83 trials (± recruiting share)
- Ferring Pharmaceuticals · 83 trials · 5% recruiting
- National Jewish Health · 83 trials · 8% recruiting
- Teva Pharmaceuticals USA · 83 trials · 0% recruiting
- Seagen · 84 trials · 0% recruiting
Sponsors near 30% open enrollment (± trial volume)
- Tulane University · 30% recruiting · 73 trials
- Adverum Biotechnologies · 30% recruiting · 10 trials
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
- Child Trends · 30% recruiting · 10 trials
Related
What to do with this New York University page
83 registered trials is a research-attention snapshot, not an endorsement of New York University or any single study.
- 25 of New York University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition New York University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. New York University pipeline card: 83 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.